The role of community advisory committees in clinical trials of anti-HIV agents.
D000163:Acquired Immunodeficiency Syndrome; D026683:Advisory Committees; D003142:Communication; D003256:Community Participation; D003219:Confidentiality; D035061:Control Groups; D030881:Disclosure; D017007:Duty to Warn; D026724:Ethical Review; D004989:Ethics; D006679:HIV Seropositivity; D006716:Homosexuality; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D016134:Organizational Policy; D004364:Pharmaceutical Preparations; D010919:Placebos; D011640:Public Policy; D011897:Random Allocation; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D014838:Volunteers
Biomedical and Behavioral Research; Health Care and Public Health; University of Pittsburgh